Global Methocarbamol Market 2023-2030

    In Stock

    Coming Soon 




    Methocarbamol, sold under the brand name Robaxin among others, is a medication used for short-term musculoskeletal pain. It may be used together with rest, physical therapy, and pain medication. It is less preferred in low back pain. It has limited use for rheumatoid arthritis and cerebral palsy. Effects generally begin within half an hour.It is taken by mouth or injection into a vein.


    Common side effect include headaches, sleepiness, and dizziness. Serious side effects may include anaphylaxis, liver problems, confusion, and seizures. Use is not recommended in pregnancy and breastfeeding. Because of risk of injury, skeletal muscle relaxants should generally be avoided in geriatric patients.


    Methocarbamol is a centrally acting muscle relaxant.How it works is unclear, but it does not appear to affect muscles directly. Methocarbamol was developed in the laboratories of A. H. Robins (later acquired by Pfizer).


    Studies were directed towards the development of propanediol derivatives which possessed muscle relaxant properties superior to those of mephenesin, which had low potency and a short duration of action.The clinical effectiveness of methocarbamol compared to other muscle relaxants is not well-known.


    One trial of methocarbamol versus cyclobenzaprine, a well-studied muscle relaxant, in those with localized muscle spasm found there was no significant differences in their effects on improved muscle spasm, limitation of motion, or limitation of daily activities.





    infographic: Methocarbamol Market , Methocarbamol Market Size, Methocarbamol Market Trends, Methocarbamol Market Forecast, Methocarbamol Market Risks, Methocarbamol Market Report, Methocarbamol Market Share.


    The Global Methocarbamol market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    AURO PHARMA Methocarbamol METHOCARBAMOL belongs to the group of medicines called ‘muscle relaxants’. It is mainly used to relieve pain and muscle spasms occurring due to acute musculoskeletal problems.


    Muscle spasm is the painful and involuntary contraction that occurs when the nerve impulses that control the muscle movements are damaged or interrupted. Secondly, it also treats tetanus conditions (lockjaw) which are characterized by painful tightening of muscles. Tetanus is a nerve disorder leading to painful muscle contraction, mainly affecting the jaw and neck muscles. 


    METHOCARBAMOL consists of methocarbamol. It works by blocking pain impulses sent to the spinal cord and brain, thereby helps to maintain muscle strength and relieving muscle spasms or stiffness. 





    1. How many Methocarbamol are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global Methocarbamol and key vendor selection criteria
    3. Where is the Methocarbamol manufactured? What is the average margin per unit?
    4. Market share of Global Methocarbamol market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global Methocarbamol in-house
    6. key predictions for next 5 years in Global Methocarbamol market
    7. Average B-2-B Methocarbamol market price in all segments
    8. Latest trends in Methocarbamol market, by every market segment
    9. The market size (both volume and value) of the Methocarbamol market in 2023-2030 and every year in between?
    10. Production breakup of Methocarbamol market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop